Gene · 1001
Papers1,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig. | Front Immunol | 2023 | 36949939 | PubTator, text mining | PubMed |
| EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway. | J Transl Med | 2023 | 36932397 | PubTator, text mining | PubMed |
| Network and pathway-based analysis of candidate genes associated with esophageal adenocarcinoma. | J Gastrointest Oncol | 2023 | 36915458 | PubTator, text mining | PubMed |
| Operative vs Nonoperative Management of Achilles Tendon Rupture: A Cost Analysis. | Foot Ankle Orthop | 2023 | 36911422 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
| Exosomes in Colorectal Cancer: From Physiology to Clinical Applications. | Int J Mol Sci | 2023 | 36901813 | PubTator, text mining | PubMed |
| Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United States. | BMC Gastroenterol | 2023 | 36894911 | PubTator, text mining | PubMed |
| Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma. | Elife | 2023 | 36892272 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-acral lesions of non-segmental vitiligo patients: a follow-up-based study in North India. | Arch Dermatol Res | 2023 | 36877308 | PubTator, text mining | PubMed |
| Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. | Signal Transduct Target Ther | 2023 | 36872368 | PubTator, text mining | PubMed |
| Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis. | Front Med (Lausanne) | 2023 | 36860337 | PubTator, text mining | PubMed |
| Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune infiltration in gastric cancer. | Heliyon | 2023 | 36852074 | PubTator, text mining | PubMed |
| Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor. | Vaccines (Basel) | 2023 | 36851271 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA. | Clin Drug Investig | 2023 | 36840815 | PubTator, text mining | PubMed |
| Stargardt-like Clinical Characteristics and Disease Course Associated with Variants in the WDR19 Gene. | Genes (Basel) | 2023 | 36833218 | PubTator, text mining | PubMed |
| Dental Phenotype with Minor Ectodermal Symptoms Suggestive of WNT10A Deficiency. | Children (Basel) | 2023 | 36832485 | PubTator, text mining | PubMed |
| The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer. | Biomedicines | 2023 | 36831075 | PubTator, text mining | PubMed |
| Activation of an actin signaling pathway in pre-malignant mammary epithelial cells by P-cadherin is essential for transformation. | Dis Model Mech | 2023 | 36808468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1001/papers?page=10